<code id='90746F183D'></code><style id='90746F183D'></style>
    • <acronym id='90746F183D'></acronym>
      <center id='90746F183D'><center id='90746F183D'><tfoot id='90746F183D'></tfoot></center><abbr id='90746F183D'><dir id='90746F183D'><tfoot id='90746F183D'></tfoot><noframes id='90746F183D'>

    • <optgroup id='90746F183D'><strike id='90746F183D'><sup id='90746F183D'></sup></strike><code id='90746F183D'></code></optgroup>
        1. <b id='90746F183D'><label id='90746F183D'><select id='90746F183D'><dt id='90746F183D'><span id='90746F183D'></span></dt></select></label></b><u id='90746F183D'></u>
          <i id='90746F183D'><strike id='90746F183D'><tt id='90746F183D'><pre id='90746F183D'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:93
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Readout Newsletter: The latest on Moderna, Apellis, and Merck
          Readout Newsletter: The latest on Moderna, Apellis, and Merck

          JakubPorzycki/NurPhotoviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetou

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Three trends to watch in biotech in 2024

          ChristineKao/STATEverywinter,likePunxsutawneynobles,biotech’smanythoughtleadersgatherfortheJ.P.Morga